Coronavirus Update - 24th June 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual.

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The expertise of the next generation and the implementation of flow chemistry in pharma

Our Head of Drug Substance, Paul Quigley, shared his insights into how the next generation of scientists are using their skills and knowledge to help bridge the gap in expertise between batch and flow technologies. In this Chemistry Today article, Paul explains how pharmaceutical companies can encourage more flow chemistry researchers to consider careers in industry. Read the article here

 




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH